FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10261611000001104: Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35463401000001110 Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
39727701000001119 Olmetec Plus 20mg/12.5mg tablets (Daiichi Sankyo UK Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Is a Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Is pack of Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) false Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has active ingredient Olmesartan medoxomil false Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has AMP Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has specific active ingredient Olmesartan medoxomil true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olmetec Plus 20mg/12.5mg tablets (Sankyo Pharma UK) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start